Cat.#: ACPP-1079
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
| ACPP-1275 | Usherin Blocking Peptide (AC1275) | 250 µg | inquiry |
| ACPP-1751 | Human HAGH Protein (AC1751) | 2 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1823 | Human SOX2 Protein, TAT (AC1823) | 5 µg | inquiry |
| ACPP-1295 | Human ASPH Protein (AC1295) | 5 µg | inquiry |
| ACPP-1197 | Dopamine Transporter Blocking Peptide (AC1197) | 250 µg | inquiry |
| ACPP-1524 | Human TARDBP (1-414) Protein (AC1524) | 5 µg | inquiry |
| ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.